Shanghai, China – 9 February, 2015 - Shanghai MicroPort Access Medtech Co ("MicroPort Access"), a subsidiary of Shanghai MicroPort Medical (Group) Co ("MicroPort"), recently gained a registration certificate for its Angiographic Catheter from China Food and Drug Administration ("CFDA"). This Angiographic Catheter includes six additional distal end configurations, such as coronary artery LRS, RH and Cobra.
MicroPort Access Angiographic Catheter is used for coronary artery angiography and peripheral vascular angiography. Its distal tip is designed with innovative "Full-radius" structure. Its extra soft material can reduce the damage of blood vessel and provide better cross ability. With six distal end configurations, the Angiographic Catheter offers more options for surgeons and is expected to increase its market share in the future.
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.